Home › Myeloproliferative Neoplasms › Massachusetts › Boston

Pag-aaral pangklinika para sa Myeloproliferative Neoplasms sa Boston, MA

14 pag-aaral para sa Myeloproliferative Neoplasms ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Boston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2

Tufts Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Tufts Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT03471260

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Brigham and Women's Hospital, Boston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07020533

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Nagre-recruitPhase 1

Mass General Brigham, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07249840

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

Nagre-recruitPhase 1

Boston Children's Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT04024761

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston
Brigham and Women's Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06138587

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

DFCI/BWH Brigham and Women's Hospital, Boston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT06059391

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

Nagre-recruit

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT05842603

Pag-aaral para sa Myeloproliferative Neoplasms sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.